CD79A and rheumatoid arthritis: •IgA anti-MAA levels improved 10-year prediction of coronary atherosclerosis in RA patients beyond standard cardiovascular risk calculation (C-statistic 0.761 with IgA anti-MAA vs. 0.733 without IgA anti-MAA) (36).